HIV persistence in tissues on dolutegravir-based therapy is not associated with resistance mutations to dolutegravir
Open Access
- 27 January 2026
- journal article
- research article
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1)
Abstract
Background Relatively few studies have investigated HIV-1 persistence in tissues, especially in healthy people-living-with-HIV-1 (PLWH) on a successful antiretroviral regimen containing second generation integrase inhibitors. Methods In the ANRS EP64 DOLUVOIR, we explore HIV-1 persistence in five accessible anatomical sites in 20 PLWH on an efficient first-line ART regimen containing dolutegravir with virological load 6 cells and 1.50 log copies of HIV-1 cell-associated-RNA/µg RNA). HIV-1 DNA is undetected in all sperm samples (n = 19) except for one (1.52 log copies HIV-1-DNA/106 cells). No difference is noted between the diversity in the four compartments. DRMs to the current regimen are found archived in compartments of six participants. Only two major DRMs to dolutegravir (G118R and R263K) are found archived in two participants. They are the results of APOBEC hypermutations. Conclusions Despite ongoing transcriptional activity, persistence of HIV-1 in deep tissues is not associated with the selection of DRMs to dolutegravir on intact proviruses. Our results suggest that the detectable transcriptional activity stems predominantly from defective proviral DNA.Keywords
Funding Information
- ViiV Healthcare
This publication has 50 references indexed in Scilit:
- Anatomical, subset, and HIV-dependent expression of viral sensors and restriction factorsCell Reports, 2025
- Intact proviruses are enriched in the colon and associated with PD-1+TIGIT− mucosal CD4+ T cells of people with HIV-1 on antiretroviral therapyEBioMedicine, 2023
- Near full-length HIV sequencing in multiple tissues collected postmortem reveals shared clonal expansions across distinct reservoirs during ARTCell Reports, 2023
- Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ARTAnnals of Neurology, 2022
- Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES studyJournal of Global Antimicrobial Resistance, 2022
- The loud minority: Transcriptionally active HIV-1-infected cells survive, proliferate, and persistCell, 2022
- Tissue‐specific differences in HIV DNA levels and mechanisms that govern HIV transcription in blood, gut, genital tract and liver in ART‐treated womenJournal of the International AIDS Society, 2021
- The Biology of the HIV-1 Latent Reservoir and Implications for Cure StrategiesCell Host & Microbe, 2020
- HIV Rebound Is Predominantly Fueled by Genetically Identical Viral Expansions from Diverse ReservoirsCell Host & Microbe, 2019
- LTR real‐time PCR for HIV‐1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01)Journal of Medical Virology, 2008